期刊
TRENDS IN IMMUNOLOGY
卷 39, 期 9, 页码 748-763出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.it.2018.07.001
关键词
-
类别
资金
- Institute Curie [Pic3i]
- Institut National de la Sante et de la Recherche Medicale
- Institut Carnot, Labex DCBIOL [ANR-10-IDEX-0001-02 PSL, ANR-11-LABX0043]
- Fondation Suisse
- [SIRIC INCa-DGOS-Inserm_12554]
Immunotherapy is revolutionizing cancer treatment; however, complete responses are achieved in only a small fraction of patients and tumor types. Thus, there is an urgent need for predictive preclinical models to drive rational immunotherapeutic drug development, treatment combinations, and to minimize failures in clinical trials. Humanized mouse models (HIS) have been developed to study and modulate the interactions between immune components and tumors of human origin. In this review, we discuss recent advances in the humanization of mouse models to improve the quality of human immune cell reconstitution. We also highlight new insights into the basic mechanisms, and provide a preclinical evaluation of onco-immunotherapies, as well as the limitations thereof, which constitute drivers for the improvement of the models to increase their translational power.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据